S. H. Adams, C. Lei, C. M. Jodka, S. E. Nikoulina, J. A. Hoyt et al., PYY[3-36] administration decreases the respiratory quotient and reduces adiposity in diet-induced obese mice, J. Nutr, vol.136, 2006.

F. Bacchi, A. A. Mathe, P. Jimenez, L. Stasi, R. Arban et al., Anxiolytic-like effect of the selective Neuropeptide Y Y2 receptor antagonist BIIE0246 in the elevated plus-maze, Peptides, vol.27, issue.12, pp.3202-3207, 2006.
DOI : 10.1016/j.peptides.2006.07.020

L. Caberlotto and Y. L. Hurd, Neuropeptide Y Y1 and Y2 Receptor mRNA Expression in the Prefrontal Cortex of Psychiatric Subjects Relationship of Y2 Subtype to Suicidal Behavior, Neuropsychopharmacology, vol.25, issue.1, pp.91-97, 2001.
DOI : 10.1016/S0893-133X(00)00231-1

C. Carvajal, Y. Dumont, H. Herzog, and R. Quirion, Emotional Behavior in Aged Neuropeptide Y (NPY) Y<sub>2</sub> Knockout Mice, Journal of Molecular Neuroscience, vol.28, issue.3, pp.239-245, 2006.
DOI : 10.1385/JMN:28:3:239

J. C. Chavez and J. C. Lamanna, Activation of hypoxia-inducible factor-1 in the rat cerebral cortex after transient global ischemia: potential role of insulin-like growth factor-1, J. Neurosci, vol.22, pp.8922-8931, 2002.

J. F. Cryan, M. E. Page, and I. Lucki, Differential behavioral effects of the antidepressants reboxetine, fluoxetine, and moclobemide in a modified forced swim test following chronic treatment, Psychopharmacology, vol.14, issue.Suppl 4, pp.335-344, 2005.
DOI : 10.1007/s00213-005-0093-5

J. F. Cryan and D. A. Slattery, Animal models of mood disorders: recent developments, Current Opinion in Psychiatry, vol.20, issue.1, pp.1-7, 2007.
DOI : 10.1097/YCO.0b013e3280117733

Y. Dumont, J. G. Chabot, and R. Quirion, Receptor autoradiography as mean to explore the possible functional relevance of neuropeptides: focus on new agonists and antagonists to study natriuretic peptides, neuropeptide Y and calcitonin gene-related peptides, Peptides, vol.25, issue.3, pp.365-391, 2004.
DOI : 10.1016/j.peptides.2004.01.013

Y. Dumont, A. Fournier, and R. Quirion, Expression and characterization of the neuropeptide Y Y5 receptor subtype in the rat brain, J. Neurosci, vol.18, pp.5565-5574, 1998.

Y. Dumont, D. Jacques, P. Bouchard, and R. Quirion, Species differences in the expression and distribution of the neuropeptide Y Y1, Y2, Y4, and Y5 receptors in rodents, guinea pig, and primates brains, The Journal of Comparative Neurology, vol.402, issue.3, pp.372-384, 1998.
DOI : 10.1002/(SICI)1096-9861(19981221)402:3<372::AID-CNE6>3.0.CO;2-2

Y. Dumont, A. Fournier, S. St-pierre, and R. Quirion, Characterization of neuropeptide Y binding sites in rat brain membrane preparations using [125I][Leu31, Pro34]peptide YY and [125I]peptide YY3-36 as selective Y1 and Y2 radioligands, J. Pharmacol. Exp. Ther, vol.272, pp.673-680, 1995.

Y. Dumont, D. Jacques, J. St-pierre, Y. Tong, R. Parker et al., Chapter IX Neuropeptide Y, peptide YY and pancreatic polypeptide receptor proteins and mRNAs in mammalian brains, Peptide Receptors, pp.375-475, 2000.
DOI : 10.1016/S0924-8196(00)80011-1

Y. Dumont, J. C. Morales-medina, and R. Quirion, Neuropeptide Y an its role in anxiety-related disorders Transmitters and Modulators in Health and Disease, pp.51-82, 2009.

Y. Dumont, E. Moyse, A. Fournier, and R. Quirion, Evidence for the Existence of an Additional Class of Neuropeptide Y Receptor Sites in Rat Brain, Journal of Pharmacology and Experimental Therapeutics, vol.315, issue.1, pp.315-99, 2005.
DOI : 10.1124/jpet.105.089300

Y. Dumont and R. Quirion, receptors, British Journal of Pharmacology, vol.125, issue.1, pp.37-46, 2000.
DOI : 10.1038/sj.bjp.0702983

URL : https://hal.archives-ouvertes.fr/inserm-00145263

Y. Dumont and R. Quirion, An overview of neuropeptide Y: pharmacology to molecular biology and receptor localization, Progress in Inflammation Research. Birkhauser Varlag, pp.7-33, 2006.
DOI : 10.1007/3-7643-7417-9_2

S. E. File, The use of social interaction as a method for detecting anxiolytic activity of chlordiazepoxide-like drugs, Journal of Neuroscience Methods, vol.2, issue.3, pp.219-238, 1980.
DOI : 10.1016/0165-0270(80)90012-6

S. E. File and P. Seth, A review of 25 years of the social interaction test, European Journal of Pharmacology, vol.463, issue.1-3, pp.35-53, 2003.
DOI : 10.1016/S0014-2999(03)01273-1

M. Forest, J. C. Martel, S. St-pierre, R. Quirion, and A. Fournier, Structural Study of the N-Terminal Segment of Neuropeptide-Tyrosine, Annals of the New York Academy of Sciences, vol.32, issue.1 Central and P, 1990.
DOI : 10.1021/jm00123a014

S. N. Goyal, M. A. Upadhya, D. M. Kokare, S. M. Bhisikar, and N. K. Subhedar, Neuropeptide Y modulates the antidepressant activity of imipramine in olfactory bulbectomized rats: Involvement of NPY Y1 receptors, Brain Research, vol.1266, pp.45-53, 1266.
DOI : 10.1016/j.brainres.2009.02.033

A. Gregus, A. J. Wintink, A. C. Davis, and L. E. Kalynchuk, Effect of repeated corticosterone injections and restraint stress on anxiety and depression-like behavior in male rats, Behavioural Brain Research, vol.156, issue.1, pp.105-114, 2005.
DOI : 10.1016/j.bbr.2004.05.013

S. Hasegawa, A. Watanabe, K. Q. Nguyen, G. Debonnel, and M. Diksic, Chronic administration of citalopram in olfactory bulbectomy rats restores brain 5-HT synthesis rates: an autoradiographic study, Psychopharmacology, vol.54, issue.Suppl, pp.781-790, 2005.
DOI : 10.1007/s00213-004-2122-1

M. Heilig, B. Soderpalm, J. A. Engel, and E. Widerlov, Centrally administered neuropeptide Y (NPY) produces anxiolytic-like effects in animal anxiety models, Psychopharmacology, vol.122, issue.1, pp.524-529, 1989.
DOI : 10.1007/BF00441953

M. Heilig, O. Zachrisson, A. Thorsell, A. Ehnvall, S. Mottagui-tabar et al., Decreased cerebrospinal fluid neuropeptide Y (NPY) in patients with treatment refractory unipolar major depression: preliminary evidence for association with preproNPY gene polymorphism, Journal of Psychiatric Research, vol.38, issue.2, pp.113-121, 2004.
DOI : 10.1016/S0022-3956(03)00101-8

P. A. Hipskind, K. L. Lobb, J. A. Nixon, T. C. Britton, R. F. Bruns et al., indole NPY Y-1 antagonists, J. Med. Chem, vol.2, issue.40, pp.3-3712, 1997.

P. V. Holmes, Rodent Models of Depression: Reexamining Validity Without Anthropomorphic Inference, Critical Reviews in Neurobiology, vol.15, issue.2, pp.143-174, 2003.
DOI : 10.1615/CritRevNeurobiol.v15.i2.30

P. V. Holmes, R. C. Davis, C. V. Masini, and S. D. Primeaux, Effects of olfactory bulbectomy on neuropeptide gene expression in the rat olfactory/limbic system, Neuroscience, vol.86, issue.2, pp.587-596, 1998.
DOI : 10.1016/S0306-4522(98)00029-3

C. Hou, F. Jia, Y. Liu, and L. Li, CSF serotonin, 5-hydroxyindolacetic acid and neuropeptide Y levels in severe major depressive disorder, Brain Research, vol.1095, issue.1, pp.154-158, 1095.
DOI : 10.1016/j.brainres.2006.04.026

A. V. Kalueff and P. Tuohimaa, Contrasting grooming phenotypes in C57Bl/6 and 129S1/SvImJ mice, Brain Research, vol.1028, issue.1, pp.75-82, 1028.
DOI : 10.1016/j.brainres.2004.09.001

L. E. Kalynchuk, A. Gregus, D. Boudreau, and T. S. Perrot-sinal, Corticosterone Increases Depression-Like Behavior, With Some Effects on Predator Odor-Induced Defensive Behavior, in Male and Female Rats., Behavioral Neuroscience, vol.118, issue.6, 2004.
DOI : 10.1037/0735-7044.118.6.1365

S. Kantor, Z. E. Anheuer, and G. Bagdy, High social anxiety and low aggression in Fawn-Hooded rats, Physiology & Behavior, vol.71, issue.5, pp.551-557, 2000.
DOI : 10.1016/S0031-9384(00)00374-7

A. Kask, J. Harro, S. Von-horsten, J. P. Redrobe, Y. Dumont et al., The neurocircuitry and receptor subtypes mediating anxiolytic-like effects of neuropeptide Y, Neuroscience & Biobehavioral Reviews, vol.26, issue.3, pp.259-283, 2002.
DOI : 10.1016/S0149-7634(01)00066-5

A. Kask, E. Vasar, L. T. Heidmets, L. Allikmets, and J. E. Wikberg, Neuropeptide Y Y5 receptor antagonist CGP71683A: the effects on food intake and anxiety-related behavior in the rat, European Journal of Pharmacology, vol.414, issue.2-3, pp.215-224, 2001.
DOI : 10.1016/S0014-2999(01)00768-3

J. P. Kelly, A. S. Wrynn, and B. E. Leonard, The olfactory bulbectomized rat as a model of depression: An update, Pharmacology & Therapeutics, vol.74, issue.3, pp.299-316, 1997.
DOI : 10.1016/S0163-7258(97)00004-1

P. J. King, P. S. Widdowson, H. N. Doods, and G. Williams, Regulation of Neuropeptide Y Release by Neuropeptide Y Receptor Ligands and Calcium Channel Antagonists in Hypothalamic Slices, Journal of Neurochemistry, vol.133, issue.2, pp.641-646, 1999.
DOI : 10.1046/j.1471-4159.1999.0730641.x

P. J. King, G. Williams, H. Doods, and P. S. Widdowson, Effect of a selective neuropeptide Y Y2 receptor antagonist, BIIE0246 on neuropeptide Y release, European Journal of Pharmacology, vol.396, issue.1, 2000.
DOI : 10.1016/S0014-2999(00)00230-2

Y. Liu and Z. X. Wang, Nucleus accumbens oxytocin and dopamine interact to regulate pair bond formation in female prairie voles, Neuroscience, vol.121, issue.3, pp.537-544, 2003.
DOI : 10.1016/S0306-4522(03)00555-4

I. Lucki, The forced swimming test as a model for core and component behavioral effects of antidepressant drugs, Behavioural Pharmacology, vol.8, issue.6, pp.523-532, 1997.
DOI : 10.1097/00008877-199711000-00010

R. Mitra and R. M. Sapolsky, Acute corticosterone treatment is sufficient to induce anxiety and amygdaloid dendritic hypertrophy, Proceedings of the National Academy of Sciences, vol.105, issue.14, pp.5573-5578, 2008.
DOI : 10.1073/pnas.0705615105

J. Morales-medina, I. Juarez, E. Venancio-garcía, S. Cabrera, G. Flores et al., Major morphological reorganization of key brain regions in the olfactory bulbectomized rat Canadian neuroscience meeting, 2010.

J. C. Morales-medina, Y. Dumont, and R. Quirion, A possible role of neuropeptide Y in depression and stress, Brain Research, vol.1314, 1314.
DOI : 10.1016/j.brainres.2009.09.077

J. C. Morales-medina and R. Quirion, Role of Neuropeptide Y in Depression, Neurobiology of Depression, 2011.
DOI : 10.1201/b11232-17

URL : https://hal.archives-ouvertes.fr/pasteur-01001776

R. Moriya, S. Mashiko, A. Ishihara, T. Takahashi, T. Murai et al., Comparison of independent and combined chronic anti-obese effects of NPY Y2 receptor agonist, PYY(3-36), and NPY Y5 receptor antagonist in diet-induced obese mice, Peptides, vol.30, issue.7, 2009.
DOI : 10.1016/j.peptides.2009.04.006

I. D. Neumann, G. Wegener, J. R. Homberg, H. Cohen, D. A. Slattery et al., Animal models of depression and anxiety: What do they tell us about human condition?, Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol.35, issue.6, 2010.
DOI : 10.1016/j.pnpbp.2010.11.028

E. Painsipp, H. Herzog, and P. Holzer, Implication of neuropeptide-Y Y2 receptors in the effects of immune stress on emotional, locomotor and social behavior of mice, Neuropharmacology, vol.55, issue.1, pp.117-126, 2008.
DOI : 10.1016/j.neuropharm.2008.05.004

E. Painsipp, T. Wultsch, M. E. Edelsbrunner, R. O. Tasan, N. Singewald et al., Reduced anxiety-like and depression-related behavior in neuropeptide Y Y4 receptor knockout mice, Genes, Brain and Behavior, vol.55, issue.Suppl. 2, pp.532-542, 2008.
DOI : 10.1111/j.1601-183X.2008.00389.x

D. K. Pandey, R. Mahesh, A. A. Kumar, V. S. Rao, M. Arjun et al., A novel 5-HT2A receptor antagonist exhibits antidepressant-like effects in a battery of rodent behavioural assays: Approaching early-onset antidepressants, Pharmacology Biochemistry and Behavior, vol.94, issue.3, pp.363-373
DOI : 10.1016/j.pbb.2009.09.018

G. Paxinos and C. Watson, The Rat Brain in Stereotaxic Coordinates, 1986.

R. D. Porsolt, M. Le-pichon, and M. Jalfre, Depression: a new animal model sensitive to antidepressant treatments, Nature, vol.50, issue.5604, pp.730-732, 1977.
DOI : 10.1038/266730a0

S. D. Primeaux and P. V. Holmes, Olfactory bulbectomy increases met-enkephalin- and neuropeptide-Y-like immunoreactivity in rat limbic structures, Pharmacology Biochemistry and Behavior, vol.67, issue.2, pp.331-337, 2000.
DOI : 10.1016/S0091-3057(00)00358-0

R. Rajkumar, D. K. Pandey, R. Mahesh, and R. Radha, 1-(m-Chlorophenyl)piperazine induces depressogenic-like behaviour in rodents by stimulating the neuronal 5-HT2A receptors: Proposal of a modified rodent antidepressant assay, European Journal of Pharmacology, vol.608, issue.1-3, pp.32-41, 2009.
DOI : 10.1016/j.ejphar.2009.02.041

J. P. Redrobe, Y. Dumont, A. Fournier, and R. Quirion, The Neuropeptide Y (NPY) Y1 Receptor Subtype Mediates NPY-induced Antidepressant-like Activity in the Mouse Forced Swimming Test, Neuropsychopharmacology, vol.26, issue.5, pp.615-624, 2002.
DOI : 10.1016/S0893-133X(01)00403-1

J. P. Redrobe, Y. Dumont, H. Herzog, and R. Quirion, Characterization of Neuropeptide Y, Y2 receptor knockout mice in two animal models of learning and memory processing, J. Mol. Neurosci, vol.22, pp.121-128, 2003.

J. P. Redrobe, Y. Dumont, H. Herzog, and R. Quirion, Neuropeptide Y (NPY) Y2 receptors mediate behaviour in two animal models of anxiety: evidence from Y2 receptor knockout mice, Behavioural Brain Research, vol.141, issue.2, pp.251-255, 2003.
DOI : 10.1016/S0166-4328(02)00374-1

S. Rotzinger, D. A. Lovejoy, and L. A. Tan, Behavioral effects of neuropeptides in rodent models of depression and anxiety, Peptides, vol.31, issue.4, pp.736-756, 2009.
DOI : 10.1016/j.peptides.2009.12.015

N. J. Rutkoski, A. A. Lerant, C. M. Nolte, J. Westberry, and C. W. Levenson, Regulation of neuropeptide Y in the rat amygdala following unilateral olfactory bulbectomy, Brain Research, vol.951, issue.1, pp.69-76, 2002.
DOI : 10.1016/S0006-8993(02)03136-0

T. J. Sajdyk, D. A. Schober, D. L. Smiley, and D. R. Gehlert, Neuropeptide Y-Y2 receptors mediate anxiety in the amygdala, Pharmacology Biochemistry and Behavior, vol.71, issue.3, pp.419-423, 2002.
DOI : 10.1016/S0091-3057(01)00679-7

T. J. Sajdyk, M. G. Vandergriff, and D. R. Gehlert, Amygdalar neuropeptide Y Y1 receptors mediate the anxiolytic-like actions of neuropeptide Y in the social interaction test, European Journal of Pharmacology, vol.368, issue.2-3, pp.143-147, 1999.
DOI : 10.1016/S0014-2999(99)00018-7

C. Song, B. Earley, and B. E. Leonard, The Effects of Central Administration of Neuropeptide Y on Behavior, Neurotransmitter, and Immune Functions in the Olfactory Bulbectomized Rat Model of Depression, Brain, Behavior, and Immunity, vol.10, issue.1, pp.1-16, 1996.
DOI : 10.1006/brbi.1996.0001

C. Song and B. E. Leonard, The olfactory bulbectomised rat as a model of depression, Neuroscience & Biobehavioral Reviews, vol.29, issue.4-5, pp.627-647, 2005.
DOI : 10.1016/j.neubiorev.2005.03.010

G. Sorensen, C. Lindberg, G. Wortwein, T. G. Bolwig, and D. P. Woldbye, Differential roles for neuropeptide Y Y1 and Y5 receptors in anxiety and sedation, Journal of Neuroscience Research, vol.3, issue.3, pp.723-729, 2004.
DOI : 10.1002/jnr.20200

K. A. Stogner and P. V. Holmes, Neuropeptide-Y exerts antidepressant-like effects in the forced swim test in rats, European Journal of Pharmacology, vol.387, issue.2, pp.9-10, 2000.
DOI : 10.1016/S0014-2999(99)00800-6

S. Tanaka, L. W. Fan, L. T. Tien, Y. Park, L. Y. Liu-chen et al., Butorphanol dependence increases hippocampal ??-opioid receptor gene expression, Journal of Neuroscience Research, vol.14, issue.2, pp.255-263, 2005.
DOI : 10.1002/jnr.20620

R. O. Tasan, S. Lin, A. Hetzenauer, N. Singewald, H. Herzog et al., Increased novelty-induced motor activity and reduced depression-like behavior in neuropeptide Y (NPY)???Y4 receptor knockout mice, Neuroscience, vol.158, issue.4, 2009.
DOI : 10.1016/j.neuroscience.2008.11.048

K. Tatemoto, M. Carlquist, and V. Mutt, Neuropeptide Y???a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide, Nature, vol.13, issue.5858, pp.659-660, 1982.
DOI : 10.1038/296659a0

S. Thakker-varia and J. Alder, Neuropeptides in depression: Role of VGF, Behavioural Brain Research, vol.197, issue.2, pp.262-278, 2009.
DOI : 10.1016/j.bbr.2008.10.006

C. T. To, Z. E. Anheuer, and G. Bagdy, Effects of acute and chronic fluoxetine treatment on CRH-induced anxiety, NeuroReport, vol.10, issue.3, pp.553-555, 1999.
DOI : 10.1097/00001756-199902250-00020

A. Tschenett, N. Singewald, M. Carli, C. Balducci, P. Salchner et al., Reduced anxiety and improved stress coping ability in mice lacking NPY-Y2 receptors, European Journal of Neuroscience, vol.5, issue.1, pp.143-148, 2003.
DOI : 10.1016/S0166-2236(98)01284-3

M. W. Walker, T. D. Wolinsky, V. Jubian, G. Chandrasena, H. Zhong et al., yl)amino] cyclohexyl]methyl]-methanesulfonamide] exerts anxiolytic-and antidepressantlike effects in rat models of stress sensitivity, The novel neuropeptide Y Y5 receptor antagonist Lu AA33810, pp.900-911, 2009.

D. Wang, Y. Noda, H. Tsunekawa, Y. Zhou, M. Miyazaki et al., Behavioural and neurochemical features of olfactory bulbectomized rats resembling depression with comorbid anxiety, Behavioural Brain Research, vol.178, issue.2, pp.262-273, 2007.
DOI : 10.1016/j.bbr.2007.01.003

A. Watanabe, Y. Tohyama, K. Q. Nguyen, S. Hasegawa, G. Debonnel et al., Regional brain serotonin synthesis is increased in the olfactory bulbectomy rat model of depression: an autoradiographic study, Journal of Neurochemistry, vol.54, issue.2, pp.469-475, 2003.
DOI : 10.1046/j.1471-4159.2003.01702.x

E. Widerlov, L. H. Lindstrom, C. Wahlestedt, and R. Ekman, Neuropeptide Y and peptide YY as possible cerebrospinal fluid markers for major depression and schizophrenia, respectively, Journal of Psychiatric Research, vol.22, issue.1, pp.69-79, 1988.
DOI : 10.1016/0022-3956(88)90030-1

J. Zhang, M. K. Matheny, N. Tumer, M. K. Mitchell, and P. J. Scarpace, Leptin antagonist reveals that the normalization of caloric intake and the thermic effect of food after high-fat feeding are leptin dependent, AJP: Regulatory, Integrative and Comparative Physiology, vol.292, issue.2, pp.868-874, 2007.
DOI : 10.1152/ajpregu.00213.2006